Define the screening objective
Candidates, cancer or model scope and program decision
PDO drug screening & organoid efficacy
Discuss a PDO drug-screening study
Share the candidates, cancer type or model scope, dose or combination plan, and priority endpoints. Our scientists will discuss the PDO models, controls, replication, assays and deliverables.
Set the screening design
PDO models, doses, combinations, controls and replication
Confirm assays and deliverables
Priority endpoints, comparison method, timeline and study report